SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
Back

Blog Archives

Published: Jul 12, 2026

Share

Does Aetna Cover ADHD Treatment in New Mexico? A 2026 Guide

Share

Written by Klarity Editorial Team

Published: Jul 12, 2026

Does Aetna Cover ADHD Treatment in New Mexico? A 2026 Guide
Table of contents
Share

Last updated: July 12, 2026

If you have Aetna insurance in New Mexico and you or a family member has been diagnosed with attention-deficit/hyperactivity disorder (ADHD), you likely have questions about what your plan covers, how prior authorization works, and whether telehealth prescribing is a viable option. This guide breaks down Aetna’s ADHD coverage in New Mexico for 2026, including the CVS/Caremark formulary, Electronic Prescribing of Controlled Substances (EPCS) requirements, New Mexico parity law protections, and how to work with your plan if a claim is denied.

Think your Aetna plan may cover ADHD treatment? Klarity Health connects New Mexico residents with licensed providers who accept many insurance plans. See if you may qualify for ADHD treatment through Klarity.

Coverage varies by plan. Verify your specific benefits before scheduling any appointment.

How Aetna Structures ADHD Coverage in New Mexico

Aetna administers pharmacy benefits for most of its commercial and ACA marketplace plans in New Mexico through CVS/Caremark, one of the largest pharmacy benefit managers (PBMs) in the United States. The CVS/Caremark formulary uses a tiered structure — typically four tiers — where lower tiers carry lower out-of-pocket costs and higher tiers require step therapy or prior authorization (PA).

For ADHD specifically, the formulary generally follows a generic-first approach: generic stimulants and non-stimulants are placed in Tier 1 or Tier 2 with no PA required, while brand-name stimulants are placed in Tier 3 or Tier 4 and typically require PA, step therapy, or both. Medical ADHD coverage (office visits, telehealth consultations, diagnostic evaluations) falls under your medical benefit rather than the pharmacy benefit and is subject to your deductible, copay, and coinsurance terms.

The specific tier placement and PA requirements on your plan may differ from the general CVS/Caremark commercial formulary depending on whether your employer has customized the drug list. Always verify your benefits at aetna.com or by calling the member services number on your insurance card.

CVS/Caremark Formulary: ADHD Medications (2026)

Stimulant Medications (Schedule II)

The following table reflects typical CVS/Caremark commercial formulary placement for ADHD stimulants in 2026. Verify your specific plan’s formulary for exact tier, PA requirements, and quantity limits.

MedicationTypeTypical TierPA Required?Notes
Amphetamine/dextroamphetamine (generic Adderall)Mixed amphetamine salts IRTier 1–2NoGeneric first-line; widely preferred
Mixed amphetamine salts ER (generic Adderall XR)Extended-release stimulantTier 2NoGeneric ER; no PA on most commercial plans
Methylphenidate IR (generic Ritalin)Methylphenidate IRTier 1–2NoGeneric first-line
Methylphenidate ER (generic Concerta/Metadate CD)Methylphenidate ERTier 1–2NoGeneric ER; no PA on most commercial plans
Dextroamphetamine (generic Dexedrine)DextroamphetamineTier 1–2NoGeneric; less commonly prescribed as first-line
Lisdexamfetamine (generic Vyvanse)Prodrug amphetamineTier 2–3Verify with planGeneric lisdexamfetamine now available; tier placement varies by plan — verify before dispensing
Adderall XR (brand)Mixed amphetamine salts ERTier 3–4YesBrand; step therapy through generic typically required
Vyvanse (brand lisdexamfetamine)Prodrug amphetamineTier 3–4YesBrand; generic lisdexamfetamine now available — CVS/Caremark may require generic step
Concerta (brand methylphenidate ER)Methylphenidate ERTier 3–4YesBrand; generic step required on most plans
Focalin XR (brand dexmethylphenidate)Dexmethylphenidate ERTier 3–4YesBrand; PA required
Mydayis (amphetamine salts ER)Extended-release stimulantTier 3–4YesPA required; for adults only
Jornay PM (methylphenidate ER)Evening-dosed stimulantTier 3–4YesPA required; novel formulation

All stimulants listed above are DEA Schedule II controlled substances. See the EPCS section below for New Mexico prescribing requirements.

Non-Stimulant Medications (Non-Controlled)

MedicationClassTypical TierPA Required?Notes
Atomoxetine (generic Strattera)SNRI/NRITier 2–3No (generic)Generic widely available; non-controlled; suitable for patients who cannot take stimulants
Strattera (brand)SNRI/NRITier 3–4YesBrand requires step through generic atomoxetine
Guanfacine ER (generic Intuniv)Alpha-2 agonistTier 1–2NoGeneric; used as monotherapy or adjunct
Intuniv (brand guanfacine ER)Alpha-2 agonistTier 3–4YesStep through generic required on most plans
Clonidine ER (generic Kapvay)Alpha-2 agonistTier 1–2NoGeneric; adjunct or monotherapy
Kapvay (brand clonidine ER)Alpha-2 agonistTier 3–4YesStep through generic required
Qelbree (viloxazine ER)SNRITier 3–4YesBrand-only; non-controlled; PA required; no generic available
Wellbutrin/bupropion (off-label)NDRI antidepressantTier 1–2NoGeneric; off-label for ADHD; non-controlled

Prior Authorization: What Aetna Requires for ADHD Medications

For brand-name stimulants and some non-stimulants, Aetna and CVS/Caremark typically require prior authorization. The PA process for ADHD medications generally requires:

  • A confirmed DSM-5 ADHD diagnosis (inattentive, hyperactive-impulsive, or combined presentation)
  • Documentation of symptom impact on functioning (school, work, daily activities)
  • For brand medications: evidence that a generic equivalent has been tried and was ineffective, caused intolerable side effects, or is clinically contraindicated
  • Prescriber attestation consistent with Aetna’s clinical policy for stimulant medications

PA request timelines under federal law are 72 hours for standard requests and 24 hours for urgent/expedited requests. If Aetna denies a PA, you have the right to appeal internally and, if the internal appeal is unsuccessful, to request an external independent review through the New Mexico Office of Superintendent of Insurance (OSI).

To initiate a PA or check the status of a pending request, call CVS/Caremark at 1-800-552-8159 or log in to your Aetna member portal.

Electronic Prescribing of Controlled Substances (EPCS) in New Mexico

New Mexico requires Electronic Prescribing of Controlled Substances (EPCS) for Schedule II medications under state law. Because all stimulant ADHD medications (amphetamine salts, methylphenidate, lisdexamfetamine, dexmethylphenidate) are DEA Schedule II controlled substances, prescribers in New Mexico must transmit these prescriptions electronically to a pharmacy that accepts EPCS. Paper prescriptions for Schedule II medications are no longer the standard practice in New Mexico.

What this means for patients seeking ADHD treatment through telehealth: the prescribing provider must use a EPCS-compliant platform, and the dispensing pharmacy must accept electronic Schedule II prescriptions. Most major chain pharmacies and many independent pharmacies are EPCS-enabled. When scheduling a telehealth ADHD appointment, confirm that the provider’s platform supports EPCS — Klarity Health providers use EPCS-compliant systems for all Schedule II prescriptions.

Non-stimulant ADHD medications — atomoxetine, guanfacine ER, clonidine ER, viloxazine (Qelbree), and off-label bupropion — are not controlled substances and are not subject to EPCS requirements. These may be prescribed through standard telehealth workflows without additional prescribing infrastructure.

New Mexico Mental Health Parity Protections

New Mexico’s mental health parity law (NMSA 1978 § 59A-23E-19 et seq.) requires that commercial insurers offering coverage for mental health and substance use disorder (MH/SUD) conditions provide benefits that are no more restrictive than benefits for comparable medical and surgical conditions. ADHD is a recognized mental health condition under the DSM-5 and is covered by parity protections.

In practice, parity means that Aetna may not impose higher copays, stricter PA requirements, more frequent step therapy, or lower visit limits for ADHD treatment than it does for analogous medical conditions. If you believe a claim denial or coverage restriction violates parity requirements, you can file a complaint with the New Mexico Office of Superintendent of Insurance (OSI) at 1-855-427-5674.

Important exception: If your employer provides coverage through a self-funded ERISA plan, New Mexico’s state parity statute does not apply directly. Self-funded employer plans are governed by federal law — the Mental Health Parity and Addiction Equity Act (MHPAEA) — rather than by state insurance regulations. The federal parity framework provides similar protections, but complaints about self-funded ERISA plans are directed to the U.S. Department of Labor rather than NM OSI.

To determine whether your plan is fully insured (state law applies) or self-funded (federal law applies), check your Summary Plan Description or call the member services number on your insurance card.

How to Appeal an Aetna ADHD Claim Denial

If Aetna denies coverage for an ADHD medication or service, you have a structured appeal process:

  1. Internal Level 1 Appeal: Submit a written appeal to Aetna within the timeframe specified in your denial notice (typically 180 days). Include supporting documentation from your provider — diagnosis records, treatment history, and clinical rationale for the requested medication.
  2. Internal Level 2 Appeal (if applicable): Some Aetna plans offer a second internal review tier. Check your denial letter for details.
  3. External Independent Review: If your internal appeal is denied, you may request an external independent review by a third-party medical reviewer. For fully insured New Mexico plans, external reviewers are coordinated through NM OSI. The reviewer’s decision is binding on Aetna.
  4. State Complaint: File a complaint with the New Mexico OSI at 1-855-427-5674 if you believe the denial violates state parity law or ACA requirements.

Your Aetna Explanation of Benefits (EOB) will include the specific clinical or administrative reason for the denial, which should be referenced in your appeal.

ADHD Treatment Through Telehealth with Aetna in New Mexico

Aetna’s telehealth coverage for mental health services in New Mexico may include ADHD evaluations, medication management visits, and follow-up appointments conducted via video or phone with a licensed provider. Under New Mexico’s telehealth parity provisions, Aetna-insured patients may be entitled to the same level of coverage for a telehealth mental health visit as for an equivalent in-person visit.

Klarity Health has 2,000+ licensed providers across the United States, including providers licensed in New Mexico who accept a wide range of insurance plans. If your Aetna plan provides in-network or out-of-network mental health benefits, a Klarity provider may be able to conduct your ADHD evaluation and, if clinically appropriate, submit an EPCS prescription electronically to your preferred pharmacy.

Ready to explore ADHD treatment options? Check if your Aetna plan may cover treatment through Klarity Health.

Useful Contacts for Aetna ADHD Coverage in New Mexico

  • Aetna Member Services: 1-800-872-3862 (or the number on your insurance card)
  • CVS/Caremark Pharmacy Benefits: 1-800-552-8159
  • Aetna Prior Authorization: Available through the Aetna member portal at aetna.com or via your provider’s office
  • New Mexico Office of Superintendent of Insurance (OSI): 1-855-427-5674
  • U.S. Department of Labor (self-funded ERISA plans): 1-866-444-3272

Frequently Asked Questions

Does Aetna cover ADHD medication in New Mexico?

Aetna plans in New Mexico typically cover ADHD medications through the CVS/Caremark pharmacy benefit. Generic stimulants and non-stimulants are usually placed in Tier 1–2 with no prior authorization required. Brand-name medications are generally Tier 3–4 and may require PA and step therapy through a generic equivalent. Coverage varies by specific plan — verify your formulary at aetna.com or call 1-800-872-3862.

Does Aetna cover Vyvanse or Adderall XR in New Mexico?

Brand Vyvanse and Adderall XR are typically Tier 3–4 on CVS/Caremark formularies and may require prior authorization. Generic lisdexamfetamine (the Vyvanse generic) and generic mixed amphetamine salts ER (the Adderall XR generic) are typically available at lower tiers with no PA requirement. If your provider believes the brand is medically necessary after a generic trial, they can submit a PA request on your behalf. Verify current formulary placement before dispensing, as tier positions may change throughout the year.

Does EPCS apply to ADHD medications with Aetna in New Mexico?

Yes. New Mexico requires Electronic Prescribing of Controlled Substances for all Schedule II medications, including all stimulant ADHD medications (amphetamine salts, methylphenidate, lisdexamfetamine, dexmethylphenidate). Your telehealth or in-person prescriber must use an EPCS-compliant platform, and your pharmacy must accept electronic Schedule II prescriptions. Non-stimulant ADHD medications (atomoxetine, guanfacine ER, clonidine ER, viloxazine) are not controlled substances and are not subject to EPCS requirements.

What parity protections apply to my Aetna ADHD coverage in New Mexico?

If your Aetna plan is a fully insured commercial or ACA marketplace plan, New Mexico’s mental health parity law (NMSA 1978 § 59A-23E-19 et seq.) applies. Aetna may not impose more restrictive coverage terms for ADHD than for comparable medical conditions. If your plan is a self-funded employer plan, federal MHPAEA parity protections apply instead. Contact NM OSI at 1-855-427-5674 for fully insured plan parity complaints, or the U.S. Department of Labor for self-funded ERISA plan complaints.

Can I get ADHD treatment through telehealth with Aetna coverage in New Mexico?

Many Aetna plans in New Mexico may cover telehealth mental health and ADHD services. Klarity Health connects New Mexico residents with licensed telehealth providers who accept a wide range of insurance plans. Coverage depends on your specific plan’s in-network and out-of-network benefit structure. Verify your telehealth mental health benefits before booking, and confirm the provider is in-network if in-network cost-sharing applies to your plan.


Disclaimer: This guide is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage terms, formulary positions, and prior authorization requirements vary by specific plan and may change throughout the year. Always verify your benefits directly with Aetna and CVS/Caremark before scheduling treatment or filling a prescription. Klarity Health is not affiliated with Aetna or CVS/Caremark.

Explore ADHD treatment with Klarity Health. Our licensed New Mexico providers may be covered by your Aetna plan. Check if you may qualify today.

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.